SARS-CoV-2 N-protein + Spike Glycoprotein S1 RBD IgG/IgM

Rapid immunochromatographic test SARS-CoV-2 IgG/IgM - Nucleocapsid (N protein) + Spike Glycoprotein S1 RBD is for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum, or plasma as an aid in rapid diagnosis of Coronavirus (Covid-19) infection.

Total sensitivity: 98.3% (95% CI*: 86.2% - 99.9%) 

Total specificity: 99.5% (95% CI*: 96.2% - 99.9%) 

Total accuracy: 98.9%(95% CI*: 96.1% - 99.9%)

* Confidence Intervals